COMPOSITIONS, DEVICES AND METHODS FOR TREATING FABRY DISEASE

Described herein are RPE cells engineered to secrete a GLA protein, as well as compositions, pharmaceutical preparations, and implantable devices comprising the engineered RPE cells, and methods of making and using the same for treating Fabry disease. L'invention concerne des cellules RPE modif...

Full description

Saved in:
Bibliographic Details
Main Authors MILLER, ROBERT JAMES, PAPAKOSTA, MARIANTHI, HEIDEBRECHT, RICHARD, SMITH, DEVYN MCKINLEY, SEWELL, JARED A, GONZALEZ, FRANCISCO CABALLERO, PERITT, DAVID, BEAUREGARD, MICHAEL, VEISEH, OMID, WAY, JEFFREY CHARLES, YIN, ZOE, BARNEY, LAUREN EMILY, JOHNSTON, ERIKA ELLEN, WOTTON, PAUL KEVIN, O'CONNOR, OWEN, MAKINO, ELINA, OBERLI, MATTHIAS ALEXANDER, CARMONA, GUILLAUME, FLUHARTY, BRIAN RICHARD
Format Patent
LanguageEnglish
French
Published 01.10.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Described herein are RPE cells engineered to secrete a GLA protein, as well as compositions, pharmaceutical preparations, and implantable devices comprising the engineered RPE cells, and methods of making and using the same for treating Fabry disease. L'invention concerne des cellules RPE modifiées pour sécréter une protéine GLA, ainsi que des compositions, des préparations pharmaceutiques et des dispositifs implantables comprenant les cellules RPE modifiées, et des méthodes de fabrication et d'utilisation de celles-ci pour le traitement de la maladie de Fabry.
Bibliography:Application Number: CA20203135025